Skip to main content
OpenTrials
Completed

NCT Number: NCT02306616

CCC Project- Acute Coronary Syndrome

To develop and implement quality improvement programs for the treatment of acute coronary syndrome (ACS) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of acute coronary syndrome.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Coronary Syndrome Cardiovascular Diseases Heart Diseases Myocardial Ischemia Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing An Zhen Hospital

Beijing, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Hospitalized patients with discharge diagnosis as acute coronary syndrome (including STEMI, NSTEMI and UAP) in 150 tertiary and 100 secondary hospitals.

Exclusion criteria

None

Treatment and study plan

Primary outcomes

  1. The overall composite of 11 performance measures for ACS care

    Time frame: Duration of hospital stay, an expected average of 1 week

    Performance measures for ACS care including:

    • Proportion of patients received aspirin at arrival
    • Proportion of patients received fibrinolytic therapy within 30 mins (STEMI)
    • Proportion of patients received primary percutaneous coronary intervention within 90 mins (STEMI)
    • Proportion of patients received reperfusion therapy (STEMI)
    • Proportion of patients with aspirin prescribed at discharge
    • Proportion of patients with clopidogrel or other P2Y12 inhibitors prescribed at discharge
    • Proportion of patients with beta-blocker prescribed at discharge
    • Proportion of patients with statin prescribed at discharge
    • Proportion of patients received evaluation of left ventricular systolic function
    • Proportion of left ventricular systolic dysfunction patients with ACEI or ARB prescribed at discharge
    • Proportion of patients received smoking cessation advice/ counseling

Sponsors and collaborators

Lead sponsor

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Other

Collaborators

  • American Heart Association
  • Chinese Society of Cardiology

Registry information

Official study title

Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Acute Coronary Syndrome

Important dates

Study start
2014
Primary completion
2020
Study completion
2020
First posted
Dec 3, 2014
Registry last updated
Jan 27, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.